Fall is the season for preventative screenings
T
Medical News
his is the time of year when we traditionally focus on two common health issues, prostate cancer and peripheral artery disease. According to the American Cancer Society, other than skin cancer, prostate cancer is the most common cancer in men. In 2021, about one man in eight will be diagnosed with prostate cancer during his lifetime. Prostate cancer is more Susan Foy likely to develop in older men and non-Hispanic black men. Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.1 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today. Early diagnosis and treatment are the keys. Russell Medical will host a prostate screening on 34 Lake Martin Living
Friday, Sept. 24, from 7:30 a.m. to 11:30 a.m. This quick and easy screening consists of a prostate-specific antigen blood test and a physician exam by Dr. Lancing Patterson, UAB Medicine urologist. The screening will be held in The Urology Clinic, Suite 100 of the Professional Building at Russell Medical. The cost is $10. Reservations are required and may be made by calling Community Relations at 256-329-7145. Peripheral artery disease is another common ailment seen often around Lake Martin. Dr. Regina Phillips, medical director for Russell’s Wound Care and Hyperbaric Medicine Center sees patients with peripheral artery disease frequently. Peripheral artery disease is a condition that develops when the arteries that supply blood to the internal organs, arms and legs become completely or partially blocked as a result of atherosclerosis. PAD affects between eight and 12 million people in the U.S. Though the symptoms may be serious, an astonishing 40 percent of people with PAD do not experience any symptoms. Phillips and her staff treat chronic wounds with underlying conditions of the disease, as well as perform non-invasive tests for PAD and counsel patients on how to manage an illness that, if left untreated, could lead to lower limb amputation and death. For more
